Clinical trialNo phase (not a drug trial)Completed
The Added Value of Contrast Enhancement for Guiding EUS-FNA in Solid Pancreatic Masses
- Outcome
- Finished, no results posted
- Phase
- No phase (not a drug trial)
- Status
- Completed
- Study type
- Interventional
- Start
- 1 January 2017
- Ended
- 1 January 2020
- Enrollment
- 150 participants
- Sites
- 1
- Primary outcomes
- Diagnostic accuracy of CEUS FNA endosonography versus standard FNA endosonography in the etiological cyto histological of pancreatic solid tumors using histology core as comparison between the two methods
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 25 August 2022
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
A prospective study designed to show the superiority of contrast guided echoendoscopy versus conventional echoendoscopy
Detailed description public domain (ClinicalTrials.gov)
A prospective study that compares the results using FNA contrast echoendoscopy versus standard FNA echoendoscopy in the diagnosis of solid pancreatic tumors
Papers 1
- Registry-listed results paperHarmonic contrast-enhanced endoscopic ultrasound fine-needle aspiration: Fact or fiction? DOI 10.4103/2303-9027.196917↗
The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.